Aceto Acquires Biotron Laboratories and Talus Mineral Company (Collectively “Biotron”), Leading Manufacturers of Specialty Ingredients for the Nutritional Supplements Industry
Aceto, the supplier of choice for life sciences and advanced technology specialty ingredients, today announced the acquisition of Biotron Laboratories and Talus Mineral Company (affiliated entities collectively referred to as Biotron herein), leading manufacturers of specialty ingredients for the nutritional supplements industry. The Biotron acquisition expands Aceto’s existing nutraceuticals business and further strengthens its life science sector presence.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220302005041/en/
The Biotron facilities in Ogden, Utah (shown) and Centerville, Utah, manufacture and supply more than 250 specialty ingredients to the nutritional supplements industry. (Photo: Business Wire)
For more than 40 years, Salt Lake City-based Biotron has been a leading manufacturer of premium specialty minerals, trace elements and other solutions for the nutritional supplements industry. It is well known for its proprietary technology for producing mineral chelates, which are widely used in nutritional supplements. Biotron’s amino-acid based chelation process results in superior quality minerals and trace elements with greater bioavailability and enhanced user tolerance. Biotron has strong research and development capabilities and two manufacturing facilities located near its Utah headquarters.
“Biotron is the latest of our recent acquisitions of exceptional life-science specialty manufacturers, and they bring important new capabilities to Aceto,” said Gilles Cottier, Chief Executive Officer of Aceto. “Over four decades they have built a strong reputation in the nutritional supplements industry for their unique mineral chelation process, high-quality trace elements and other specialty ingredients. They are known for their focus on R&D and ability to work with customers on a variety of custom and specialty orders. Biotron is a great addition to our already-substantial nutraceuticals business, with a complementary portfolio of customers. We are delighted to welcome them to the growing Aceto family of life science specialty manufacturers and suppliers.”
Gameil T. Fouad, PhD, President of Biotron Laboratories, commented, “At Biotron we are very proud of what our team has accomplished over the past 40 years. Our scientist-founder, my father, imbued Biotron with a passion for science and quality that has characterized the company throughout our decades of growth. Aceto shares these principles and joining forces is the logical next step in enabling the continued growth and evolution of our business.” CEO of Talus Mineral Company, Dave Johnson, added, “As part of the Aceto family, we are excited to bring our unique capabilities to serve more clients globally as well as continuing to deepen our relationships with existing customers and suppliers. We look forward to investing further in our site capabilities and continuing to offer unparalleled customer service to all our clients.”
Biotron Laboratories is certified to the NSF/GMP standard and is registered as an FDA food facility.
G2 Capital Advisors, LLC and Foley & Lardner, LLP advised Biotron Laboratories and Talus Mineral Company on the transaction. Ulmer & Berne, LLP advised Aceto. Financial terms of the transaction were not disclosed.
About Aceto
Aceto is the supplier of choice for differentiated specialty materials in the life sciences and advanced technology end markets. With business operations in 10 countries, Aceto manufactures and supplies more than 3,000 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries. In the last two years, Aceto has made seven acquisitions, including Biotron, which has expanded its manufacturing, R&D, and portfolio offerings, transforming the company into a worldwide supplier of critical ingredients with a robust manufacturing footprint. Aceto’s global operations, including a significant presence on the ground in China, India, Europe and North America, enable the company’s deep worldwide sourcing and regulatory capabilities. Aceto is well positioned to innovate new solutions, ensure quality and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide. For more information visit aceto.com.
About Biotron Laboratories and Talus Mineral Company (Collectively “Biotron”)
Biotron Laboratories and Talus Mineral Company (“Biotron”), founded in 1979 and 2014, respectively, are affiliated entities that in partnership manufacture and supply leading specialty minerals and nutritional ingredients to global markets. Biotron provides clients excellent customer service, agile processing capabilities, and proprietary production methods to deliver the highest quality ingredients with speed and certainty. The company provides over 250 products, including mineral complexes, custom blends, fortified blends, and chelates, which include magnesium-based, zinc-based, calcium-based and iron-based products. Products include halal, kosher, vegan and organic certified options. Biotron’s manufacturing operations are located in Centerville, Utah and Ogden, Utah. For more information visit https://www.biotronlabs.com/index.php and http://www.talusminerals.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220302005041/en/
Contact information
Media:
Chris Anderson
Brandwidth Solutions
canderson@brandwidthsolutions.com
+1 (207) 232-7007
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Tigo Energy Adds Solar-Plus-Storage Portfolio in Czech Republic to Build on MLPE Success8.7.2025 07:00:00 EEST | Press release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced that the Company’s entire portfolio of three-phase Tigo EI Inverters has successfully passed the certification tests for compliance with the PPDS P4 requirements in the Czech Republic. Compliance with PPDS P4, formally known as Distribution System Operation Rules, Annex 4, is a prerequisite for grid connection of solar inverters in the Czech Republic, validating the compatibility with the technical conditions defined by the European Commission and adopted by local utility companies. In the wake of the proliferation of rapid shutdown requirements across Europe, with installers in the Czech Republic deploying nearly 107MW of Tigo MLPE in 2024, Tigo products have been deployed by thousands of Czech installers in the past decade. As an established brand trusted in the Czech solar installer community, the release of the Tigo EI Residential system cap
Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial8.7.2025 07:00:00 EEST | Press release
Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Through this collaboration, LabPMM (Invivoscribe’s global reference laboratories) have customized their multiparametric flow cytometry (MFC) services and implemented their sensitive MFC AML MRD assay to supportCERo’s clinical trial of its lead compound, CER-1236. The trial targets Acute Myeloid Leukemia (AML) in patients who are relapsed/refractory, in remission with MRD, or newly diagnosed with TP53-mutated MDS/AML. AML is an aggressive blood cancer characterized by the rapid accumulation of abnormal myeloid cells in the bone marrow and blood, disrupting normal hematopoiesis.1 Treating AML is especially complex due to its genetic heterogeneity and the high risk of relapse. CAR-T (chime
Murata Launches World’s First High-Frequency Filter Using XBAR Technology for 5G, Wi-Fi 7, and Future 6G Networks8.7.2025 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has announced the mass production and commercial shipment of the world’s first*1 high-frequency filter using XBAR technology*2. Developed by combining Murata’s proprietary Surface Acoustic Wave (SAW) filter expertise with XBAR technology from Murata's subsidiary Resonant Inc., it enables the extraction of desired signals while achieving both low insertion loss and high attenuation. These features are critical for the latest wireless technologies, including 5G, Wi-Fi 6E, Wi-Fi 7, and emerging 6G technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707682186/en/ [Murata Manufacturing Co., Ltd.] The world’s first high-frequency filter using XBAR technology The demand for reliable high-frequency communications continues to grow in response to the widespread deployment of 5G and the future development of 6G. Simultaneously, wireless local-area network (W
YES Delivers Multiple VertaCure LX Systems7.7.2025 22:34:00 EEST | Press release
Yield Engineering Systems (YES), a leading provider of process equipment for AI and HPC semiconductor applications, today announced the delivery of multiple VertaCure™ LX curing systems to one of Taiwan’s top outsourced semiconductor assembly and test (OSAT) providers. These systems will support advanced packaging processes for Edge Computing and HPC solutions, delivering critical low-temperature curing, annealing, and degassing for WLCSP, Plated Bump, and Cu Pillar applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703001376/en/ VertaCure LX The VertaCure LX is a fully automated vacuum curing and degassing system engineered to ensure uniform temperature distribution and precise control of heating and cooling rates. This results in complete solvent removal, improved film properties, elimination of outgassing after cure, and outstanding particle performance. YES products have consistently demonstrated superior qu
Nakiki SE plans strategic realignment toward a “pure” Bitcoin treasury strategy7.7.2025 21:31:00 EEST | Press release
Nakiki SE (ISIN: DE000WNDL300) is planning a strategic realignment with the aim of becoming the first German listed company with a pure Bitcoin treasury strategy. A Bitcoin treasury strategy means that a company focuses its investments on Bitcoin. The course for building a Bitcoin portfolio was set today following discussions with potential investors, placing banks, and Bitcoin experts. At the annual general meeting to be held in the second half of 2025, a change of name will be proposed in addition to an adjustment of the company's purpose. In addition, discussions are being held with anchor investors to secure the funds required to finance the Bitcoin portfolio through capital increases. Language: English Company: Nakiki SE Hanauer Landstr. 204 60314 Frankfurt on the Main Germany E-mail: info@nakikifinance.com Internet: https://nakikifinance.com/ ISIN: DE000WNDL300, DE000WNDL318 WKN: WNDL30, WNDL31 Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom